INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. FILES APPLICATION FOR "IMIDAZOLINONE DERIVATIVE FOR USE IN THE TREATMENT OF TUMORS IN COMBINATION WITH RDC"

GENEVA, Sept. 21 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (4th Floor, Building 2, No. 319, Tsingtao Brewery AvenueWenjiang DistrictChengdu City, Sichuan) filed a patent application (PCT/IB2025/052558) for "IMIDAZOLINONE DERIVATIVE FOR USE IN THE TREATMENT OF TUMORS IN COMBINATION WITH RDC" on Mar 10, 2025. With publication no. WO/2025/191451, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEI, Yonggang (4th Floor, Building 2, No. 319, Tsingtao Brewery AvenueWenjiang DistrictChengdu City, Sichuan), SUN, Yi (4th Floo...